Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer
2023 · Journal of Medicinal Chemistry · 19 citations
https://doi.org/10.1021/acs.jmedchem.3c01242
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
81
Citations
4
h-index
4
i10-index
Chunlong Zhao is an academic researcher from University of Groningen. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways. The author has an h-index of 4, co-authored 9 publications.
ORCID: 0000-0001-7920-8231https://doi.org/10.1021/acs.jmedchem.3c01242
https://doi.org/10.1016/j.ejca.2025.115263
Click to start Chat